Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(6S,9R,12S,15S,18S)-1-amino-18-((S)-1-((S)-2-((S)-1-((2S,3S)-1-((R)-1-amino-3-mercapto-1-oxopropan-2-ylamino)-3-methyl-1-oxopentan-2-ylamino)-4-carboxy-1-oxobutan-2-ylcarbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-ylcarbamoyl)-6-((S)-1-((6R,9R,12S,15S)-15-(carboxymethyl)-12-(hydroxymethyl)-6,9-bis(mercaptomethyl)-1,4,7,10,13-pentaoxo-1-phenyl-2,5,8,11,14-pentaazahexadecane)pyrrolidine-2-carboxamido)-12-(3-guanidinopropyl)-15-(4-hydroxybenzyl)-1-imino-9-(mercaptomethyl)-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazaicosan-20-oic acid
ID: ALA4763515
Chembl Id: CHEMBL4763515
PubChem CID: 162659521
Max Phase: Preclinical
Molecular Formula: C80H117N25O25S4
Molecular Weight: 1957.23
Molecule Type: Unknown
Associated Items: